Metraipolis › archive › dc_7ca20f208b0f

Characterization of a Bioprinted Anticancer Cell Therapy System Generated with Continuous Liquid Interface Production — Europe PMC PMID:41583922

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41583922
DOI
10.1002/anbr.202500062
License (as archived)
solo-consultazione
Archived
2026-11-09T15:19:29.716Z
SHA-256 of the archived text
a652441eef21fb3a4c0881b01defaa29b579b57822e47550fcb101346f60ffca
Stable URL of this page
https://metraipolis.com/documento/dc_7ca20f208b0f

How to cite

Characterization of a Bioprinted Anticancer Cell Therapy System Generated with Continuous Liquid Interface Production — Europe PMC PMID:41583922 — Europe PMC (en), https://europepmc.org/article/MED/41583922 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ca20f208b0f (Metraipolis archive dc_7ca20f208b0f, sha256 a652441eef21fb3a4c0881b01defaa29b579b57822e47550fcb101346f60ffca)
BibTeX
@misc{dc7ca20f208b0f,
  title = {Characterization of a Bioprinted Anticancer Cell Therapy System Generated with Continuous Liquid Interface Production — Europe PMC PMID:41583922},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41583922},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ca20f208b0f; sha256 a652441eef21fb3a4c0881b01defaa29b579b57822e47550fcb101346f60ffca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41583922. Agents can read the archived copy with the MCP tool read_document.